Webinar on Clinical Medicine | New Developments about Portal Vein Thrombosis in Cirrhosis
6th Webinar on Clinical Medicine : New Developments about Portal Vein Thrombosis in Cirrhosis
« Portal vein thrombosis (PVT) frequently affects patients with cirrhosis. However, while in the absence of cirrhosis PVT frequently relies on underlying pro-thrombotic factors (and consequently the need of anticoagulation is obvious), in the context of cirrhosis PVT is considered to be secondary to liver disease, and whether PVT is a cause or a consequence of impaired liver function is controversial.
In contrast with the formal suggestion to treat with anticoagulants PVT in the context of cirrhosis, the issue of the management of PVT remains controversial. Actually, in clinical practice, the decision in most of the cases is not to treat due to the fear for an increased bleeding risk. Additionally, accumulating evidence suggests that spontaneous recanalization of PVT may occur without treatment.
This webinar has the aim of exploring open issues regarding PVT in cirrhosis, in particular about pathophysiology, outcome and management. »
22 mars 2022